Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice

Circulation Research

Volumn 116, Issue 8, 2015, Pages e57-e68

  Grandoch, Maria ^a,b   Feldmann, Kathrin ^a,b   Göthert, Joachim R ^f   Dick, Lena S ^a,b   Homann, Susanne ^a,b   Klatt, Christina ^a,b   Bayer, Julia K ^a,b   Waldheim, Jan N ^a,b   Rabausch, Berit ^a,b   Nagy, Nadine ^a,b   Oberhuber, Alexander ^c   Deenen, René ^d   Köhrer, Karl ^d   Lehr, Stefan ^g   Homey, Bernhard ^e   Pfeffer, Klaus ^a   Fischer, Jens W ^a,b  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b Cardiovascular Research Institute Düsseldorf CARID   (United States)

^c Klinik für Gefäß und Endovaskularchirurgie   (Germany)

^d Biologisch Medizinisches Forschungszentrum   (Germany)

^e Institut für Medizinische Mikrobiologie und Krankenhaushygiene   (Germany)

^f UNIVERSITY HOSPITAL ESSEN   (Germany)

^g LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

Atherosclerosis; Chemokine CCL5; Inflammation; Lymphotoxin beta receptor; Monocyte

Indexed keywords

APOLIPOPROTEIN E; CHEMOKINE RECEPTOR CCR5; CIRCULATING LYMPHOCYTE ANTIGEN 6C; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; LYMPHOCYTE ANTIGEN; LYMPHOTOXIN BETA RECEPTOR; RANTES; RECEPTOR ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CCL5 PROTEIN, MOUSE; LTBR PROTEIN, MOUSE; LY ANTIGEN; LY-6C ANTIGEN, MOUSE; LYMPHOTOXIN ALPHA BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; AORTA ROOT; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; BONE MARROW; CELL MIGRATION; CELL PROLIFERATION; CHIMERA; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; DOWN REGULATION; FLOW CYTOMETRY; HEMATOPOIETIC CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; MALE; MICROARRAY ANALYSIS; MONOCYTE; MONOCYTOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; TRANSCRIPTION REGULATION; WESTERN DIET; ANIMAL; AORTA; AORTIC DISEASES; ATHEROSCLEROSIS; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; C57BL MOUSE; CELL CULTURE; CHEMOTAXIS; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HISTOCOMPATIBILITY; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; NEUTROPHIL; PATHOLOGY; TIME;

ANIMALS; ANTIGENS, LY; AORTA; AORTIC DISEASES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; B-LYMPHOCYTES; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; CHEMOKINE CCL5; CHEMOTAXIS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; LYMPHOTOXIN ALPHA1, BETA2 HETEROTRIMER; LYMPHOTOXIN BETA RECEPTOR; MACROPHAGES; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; NEUTROPHILS; PLAQUE, ATHEROSCLEROTIC; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSPLANTATION CHIMERA;

EID: 84929443400     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.305723     Document Type: Article

References (55)

1. Locksley RM, Killeen N, Lenardo MJ., The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001; 104: 487-501.
2. Murphy M, Walter BN, Pike-Nobile L, Fanger NA, Guyre PM, Browning JL, Ware CF, Epstein LB., Expression of the lymphotoxin beta receptor on follicular stromal cells in human lymphoid tissues. Cell Death Differ 1998; 5: 497-505. doi: 10.1038/sj.cdd.4400374
3. Browning JL, Sizing ID, Lawton P, Bourdon PR, Rennert PD, Majeau GR, Ambrose CM, Hession C, Miatkowski K, Griffiths DA, Ngam-ek A, Meier W, Benjamin CD, Hochman PS., Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes. J Immunol 1997; 159: 3288-3298.
4. Chaplin DD, Fu Y., Cytokine regulation of secondary lymphoid organ development. Curr Opin Immunol 1998; 10: 289-297.
5. Young J, Yu X, Wolslegel K, Nguyen A, Kung C, Chiang E, Kolumam G, Wei N, Wong WL, DeForge L, Townsend MJ, Grogan JL., Lymphotoxin-alphabeta heterotrimers are cleaved by metalloproteinases and contribute to synovitis in rheumatoid arthritis. Cytokine 2010; 51: 78-86. doi: 10.1016/j.cyto.2010.03.003
6. Stopfer P, Obermeier F, Dunger N, Falk W, Farkas S, Janotta M, Möller A, Männel DN, Hehlgans T., Blocking lymphotoxin-beta receptor activation diminishes inflammation via reduced mucosal addressin cell adhesion molecule-1 (MAdCAM-1) expression and leucocyte margination in chronic DSS-induced colitis. Clin Exp Immunol 2004; 136: 21-29. doi: 10.1111/j.1365-2249.2004.02402.x
7. Seleznik GM, Reding T, Romrig F, Saito Y, Mildner A, Segerer S, Lymphotoxin beta receptor signaling promotes development of autoimmune pancreatitis. Gastroenterology 2012; 143: 1361-1374. doi: 10.1053/j.gastro.2012.07.112
8. Gommerman JL, Giza K, Perper S, Sizing I, Ngam-Ek A, Nickerson-Nutter C, Browning JL., A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT. J Clin Invest 2003; 112: 755-767. doi: 10.1172/JCI18648
9. Edgel KA, Leboeuf RC, Oram JF., Tumor necrosis factor-alpha and lymphotoxin-alpha increase macrophage ABCA1 by gene expression and protein stabilization via different receptors. Atherosclerosis 2010; 209: 387-392. doi: 10.1016/j.atherosclerosis.2009.10.019
10. Wei CY, Chou YH, Ho FM, Hsieh SL, Lin WW., Signaling pathways of LIGHT induced macrophage migration and vascular smooth muscle cell proliferation. J Cell Physiol 2006; 209: 735-743. doi: 10.1002/jcp.20742
11. Chang YH, Hsieh SL, Chao Y, Chou YC, Lin WW., Proinflammatory effects of LIGHT through HVEM and LTbetaR interactions in cultured human umbilical vein endothelial cells. J Biomed Sci 2005; 12: 363-375. doi: 10.1007/s11373-005-1360-5
12. Lo JC, Wang Y, Tumanov AV, Bamji M, Yao Z, Reardon CA, Getz GS, Fu YX., Lymphotoxin beta receptor-dependent control of lipid homeostasis. Science 2007; 316: 285-288. doi: 10.1126/science.1137221
13. Grabner R, Lotzer K, Dopping S, Hildner M, Radke D, Beer M, Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged apoe-/-mice. J Exp Med 2009; 206: 233-248. doi: 10.1084/jem.20080752
14. Weih F, Gräbner R, Hu D, Beer M, Habenicht AJ., Control of dichotomic innate and adaptive immune responses by artery tertiary lymphoid organs in atherosclerosis. Front Physiol 2012 3 226. doi: 10.3389/fphys.2012.00226
15. Owens AW, Matulevicius S, Rohatgi A, Ayers CR, Das SR, Khera A, McGuire DK, de Lemos JA., Circulating lymphotoxin β receptor and atherosclerosis: observations from the Dallas Heart Study. Atherosclerosis 2010; 212: 601-606. doi: 10.1016/j.atherosclerosis.2010.06.003
16. Dai G, Freudenberger T, Zipper P, Melchior A, Grether-Beck S, Rabausch B, de Groot J, Twarock S, Hanenberg H, Homey B, Krutmann J, Reifenberger J, Fischer JW., Chronic ultraviolet B irradiation causes loss of hyaluronic acid from mouse dermis because of down-regulation of hyaluronic acid synthases. Am J Pathol 2007; 171: 1451-1461. doi: 10.2353/ajpath.2007.070136
17. Schmittgen TD, Livak KJ., Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3: 1101-1108.
18. Hehlgans T, Müller P, Stopfer P, Männel DN., Activation of the lymphotoxin-beta receptor induces NFkappaB-dependent interleukin-6 and MIP-2 secretion in mouse fibrosarcoma cells. Eur Cytokine Netw 2003; 14: 103-107.
19. Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek R, Llodra J, Garin A, Liu J, Mack M, van Rooijen N, Lira SA, Habenicht AJ, Randolph GJ., Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 2007; 117: 185-194. doi: 10.1172/JCI28549
20. Fütterer A, Mink K, Luz A, Kosco-Vilbois MH, Pfeffer K., The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 1998; 9: 59-70.
21. Swirski FK, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P, Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009; 325: 612-616. doi: 10.1126/science.1175202
22. Robbins CS, Chudnovskiy A, Rauch PJ, Figueiredo JL, Iwamoto Y, Gorbatov R, Extramedullary hematopoiesis generates ly-6c(high) monocytes that infiltrate atherosclerotic lesions. Circulation 2012; 125: 364-374. doi: 10.1161/CIRCULATIONAHA.111.061986
23. Ngo VN, Korner H, Gunn MD, Schmidt KN, Riminton DS, Cooper MD, Browning JL, Sedgwick JD, Cyster JG., Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J Exp Med 1999; 189: 403-412.
24. Husson H, Lugli SM, Ghia P, Cardoso A, Roth A, Brohmi K, Carideo EG, Choi YS, Browning J, Freedman AS., Functional effects of TNF and lymphotoxin alpha1beta2 on FDC-like cells. Cell Immunol 2000; 203: 134-143. doi: 10.1006/cimm.2000.1688
25. Ishida S, Yamane S, Ochi T, Nakano S, Mori T, Juji T, Fukui N, Itoh T, Suzuki R., LIGHT induces cell proliferation and inflammatory responses of rheumatoid arthritis synovial fibroblasts via lymphotoxin beta receptor. J Rheumatol 2008; 35: 960-968.
26. Anders RA, Subudhi SK, Wang J, Pfeffer K, Fu YX., Contribution of the lymphotoxin beta receptor to liver regeneration. J Immunol 2005; 175: 1295-1300.
27. Wimmer N, Heigl U, Klingseisen L, Schneider-Brachert W, Hehlgans T., Lymphotoxin-beta receptor signalling regulates cytokine expression via TRIM30α in a TRAF3-dependent manner. Mol Immunol 2013; 54: 40-47. doi: 10.1016/j.molimm.2012.10.036
28. Auffray C, Fogg D, Garfa M, Elain G, Join-Lambert O, Kayal S, Sarnacki S, Cumano A, Lauvau G, Geissmann F., Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 2007; 317: 666-670. doi: 10.1126/science.1142883
29. Swirski FK, Libby P, Aikawa E, Alcaide P, Luscinskas FW, Weissleder R, Pittet MJ., Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest 2007; 117: 195-205. doi: 10.1172/JCI29950
30. Randolph GJ, Jakubzick C, Qu C., Antigen presentation by monocytes and monocyte-derived cells. Curr Opin Immunol 2008; 20: 52-60. doi: 10.1016/j.coi.2007.10.010
31. Wu H, Gower RM, Wang H, Perrard XY, Ma R, Bullard DC, Burns AR, Paul A, Smith CW, Simon SI, Ballantyne CM., Functional role of CD11c+ monocytes in atherogenesis associated with hypercholesterolemia. Circulation 2009; 119: 2708-2717. doi: 10.1161/CIRCULATIONAHA.108.823740
32. Combadière C, Potteaux S, Rodero M, Simon T, Pezard A, Esposito B, Merval R, Proudfoot A, Tedgui A, Mallat Z., Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 2008; 117: 1649-1657. doi: 10.1161/CIRCULATIONAHA.107.745091
33. Woollard KJ, Geissmann F., Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol 2010; 7: 77-86. doi: 10.1038/nrcardio.2009.228
34. McLaren JE, Ramji DP., Interferon gamma: a master regulator of atherosclerosis. Cytokine Growth Factor Rev 2009; 20: 125-135. doi: 10.1016/j.cytogfr.2008.11.003
35. Pilette C, Ouadrhiri Y, Van Snick J, Renauld JC, Staquet P, Vaerman JP, Sibille Y., IL-9 inhibits oxidative burst and TNF-alpha release in lipopolysaccharide-stimulated human monocytes through TGF-beta. J Immunol 2002; 168: 4103-4111.
36. Bsibsi M, Bajramovic JJ, Vogt MH, van Duijvenvoorden E, Baghat A, Persoon-Deen C, Tielen F, Verbeek R, Huitinga I, Ryffel B, Kros A, Gerritsen WH, Amor S, van Noort JM., The microtubule regulator stathmin is an endogenous protein agonist for TLR3. J Immunol 2010; 184: 6929-6937. doi: 10.4049/jimmunol.0902419
37. Guarda G, Braun M, Staehli F, Tardivel A, Mattmann C, Förster I, Farlik M, Decker T, Du Pasquier RA, Romero P, Tschopp J., Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 2011; 34: 213-223. doi: 10.1016/j.immuni.2011.02.006
38. Weber C, Koenen RR., Fine-tuning leukocyte responses: towards a chemokine 'interactome'. Trends Immunol 2006; 27: 268-273. doi: 10.1016/j.it.2006.04.002
39. von Hundelshausen P, Weber KS, Huo Y, Proudfoot AE, Nelson PJ, Ley K, Weber C., RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 2001; 103: 1772-1777.
40. Veillard NR, Kwak B, Pelli G, Mulhaupt F, James RW, Proudfoot AE, Mach F., Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice. Circ Res 2004; 94: 253-261. doi: 10.1161/01.RES.0000109793.17591.4E
41. Kuziel WA, Dawson TC, Quinones M, Garavito E, Chenaux G, Ahuja SS, Reddick RL, Maeda N., CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice. Atherosclerosis 2003; 167: 25-32.
42. Braunersreuther V, Zernecke A, Arnaud C, Liehn EA, Steffens S, Shagdarsuren E, Bidzhekov K, Burger F, Pelli G, Luckow B, Mach F, Weber C., Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2007; 27: 373-379. doi: 10.1161/01.ATV.0000253886.44609.ae
43. Ruddell RG, Knight B, Tirnitz-Parker JE, Akhurst B, Summerville L, Subramaniam VN, Olynyk JK, Ramm GA., Lymphotoxin-beta receptor signaling regulates hepatic stellate cell function and wound healing in a murine model of chronic liver injury. Hepatology 2009; 49: 227-239. doi: 10.1002/hep.22597
44. Lotzer K, Dopping S, Connert S, Grabner R, Spanbroek R, Lemser B, Mouse aorta smooth muscle cells differentiate into lymphoid tissue organizer-like cells on combined tumor necrosis factor receptor-1/lymphotoxin beta-receptor nf-kappab signaling. Arterioscler Thromb Vasc Biol 2010; 30: 395-402. doi: 10.1161/ATVBAHA.109.191395
45. Lasky LA, Singer MS, Dowbenko D, Imai Y, Henzel WJ, Grimley C, Fennie C, Gillett N, Watson SR, Rosen SD., An endothelial ligand for L-selectin is a novel mucin-like molecule. Cell 1992; 69: 927-938.
46. Ley K., The role of selectins in inflammation and disease. Trends Mol Med 2003; 9: 263-268.
47. Heiss A, DuChesne A, Denecke B, Grötzinger J, Yamamoto K, Renné T, Jahnen-Dechent W., Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles. J Biol Chem 2003; 278: 13333-13341. doi: 10.1074/jbc.M210868200
48. Kashyap RS, Nayak AR, Deshpande PS, Kabra D, Purohit HJ, Taori GM, Daginawala HF., Inter-alpha-trypsin inhibitor heavy chain 4 is a novel marker of acute ischemic stroke. Clin Chim Acta 2009; 402: 160-163.
49. Paclik D, Danese S, Berndt U, Wiedenmann B, Dignass A, Sturm A., Galectin-4 controls intestinal inflammation by selective regulation of peripheral and mucosal T cell apoptosis and cell cycle. PLoS One 2008 3 e2629. doi: 10.1371/journal.pone.0002629
50. Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RV Jr, Broxmeyer HE, Charo IF., Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 1997; 100: 2552-2561. doi: 10.1172/JCI119798
51. Kyaw T, Tay C, Krishnamurthi S, Kanellakis P, Agrotis A, Tipping P, Bobik A, Toh BH., B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions. Circ Res 2011; 109: 830-840. doi: 10.1161/CIRCRESAHA.111.248542
52. Drechsler M, Megens RT, van Zandvoort M, Weber C, Soehnlein O., Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation 2010; 122: 1837-1845. doi: 10.1161/CIRCULATIONAHA.110.961714
53. Gomez D, Owens GK., Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc Res 2012; 95: 156-164. doi: 10.1093/cvr/cvs115
54. Wight TN, Merrilees MJ., Proteoglycans in atherosclerosis and restenosis: key roles for versican. Circ Res 2004; 94: 1158-1167. doi: 10.1161/01.RES.0000126921.29919.51
55. Nakashima Y, Fujii H, Sumiyoshi S, Wight TN, Sueishi K., Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltration. Arterioscler Thromb Vasc Biol 2007; 27: 1159-1165. doi: 10.1161/ATVBAHA.106.134080